H3Africa Collaborative Research Center

Eyes of Africa: The Genetics of Blindness 

The Goal: To understand the genetics of glaucoma in Africans and to use this knowledge to develop and inform Africans of novel treatment strategies.

Project Leads

Dr. Adeyinka Ashaye

University of Ibadan

Dr. Chimdi Chuka-Okosa

University of Nigeria

Dr. Naa Naamuah M. Tagoe

University of Ghana Medical School

Dr. Joseph Matiya Msosa

Lions Sight-First Eye Hospital

Dr. Chinedu Anthony Okeke

Nigerian Navy Reference Hospital

Dr. Stephen Cook

The Eye Center

Dr. Michael Hauser

Duke University

The Problem

Primary open angle glaucoma (POAG) is the most common single cause of permanent blindness in Africa. Progressive vision loss associated with POAG can go unnoticed by the patient until it reaches advanced stages, and treatment strategies are not robust or widely available. Furthermore, POAG is more clinically aggressive and occurs at an earlier age in African populations compared to other populations. Finally, glaucoma and blindness are highly stigmatized within local communities, placing a social burden on those affected and their families.

Project Strategy

  1. Collect DNA samples from 8,000 healthy and affected individuals (and their families) from six recruitment sites across the continent.
  2. Analyze and compare these samples to determine how one’s genes affect their risk of being affected by glaucoma to inform novel treatment strategies.
  3. Engage communities to educate Africans on how glaucoma affects one’s vision and when to visit an eye doctor, encouraging affected individuals to begin treatment sooner to mitigate the impact of the disease.

Outcomes & Impact

Genetics of glaucoma: Analysis of 4,000 archival DNA samples identified APBB2, a new genetic risk factor for glaucoma that is found only in individuals of African ancestry. This risk factor is also involved in Alzheimer’s disease, raising the possibility of new treatments that could help patients with both diseases. The researchers have now collected an additional 6,500 samples that are being analyzed in order to replicate and extend these findings. They plan to complete collection of the planned 8,000 samples by the end of the project.

Baseline Clinical Data: Many ocular measurements have been collected on African glaucoma patients as well as healthy controls, and this data will lead to improved diagnosis and characterization of glaucoma.

Community Engagement: Multiple community engagement and educational meetings have been conducted, and the results of these meetings are published.

Capacity Building: Multiple eye clinics have received state-of-the-art diagnostic equipment which is improving patient care.

Education: Education and training builds future research capacity.  Many clinical staff have been trained in patient care, and the project statistician has learned modern genetic analysis.

Sustainability: Thousands of plasma samples have been collected, and can be used in the future to identify metabolomic and environmental risk factors in glaucoma. Two new NIH-funded grants include the Eyes of Africa data and personnel. A scientific advisory board for this project has been established.

Project Sites

A: Nigeria
University of Ibadan, University of Nigeria, Nigerian Navy Reference Hospital

B: Ghana
Lions International Eye Centre, Korle-Bu Teaching Hospital

C: South Africa
The Eye Centre

D: Malawi
Lions Sight-First Eye Hospital

Non-African Collaborators:
USA: Duke University


This work is supported by the U.S. National Institutes of Health (NIH), Office of the Director (OD), the National Eye Institute (NEI), and the National Human Genome Research Institute (NHGRI) grant number U54HG009826.
May 21, 2021

Eyes of Africa

Sickle cell disease (SCD) is the commonest genetic disorder in the World. It is most prevalent in Africa. We have established SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa to build capacity locally to enable African scientists study genomics of SCD on the continent
January 29, 2021


AWI-Gen is the Africa Wits-INDEPTH partnership for Genomic Studies, an NIH funded and university supported Collaborative Center of the Human Heredity and Health in Africa
January 29, 2021

H3Africa Administrative Coordinating Center (H3ACC)

AWI-Gen is the Africa Wits-INDEPTH partnership for Genomic Studies, an NIH funded and university supported Collaborative Center of the Human Heredity and Health in Africa
October 8, 2020

Breast Milk Microbiota Influence on Infant Immunity and Growth (BEAMING)

Understanding microbial shifts and how they affect vaccine response is central to this study. We will determine if gut microbial communities associated with breastfeeding in the HEU infant follows the same successional trajectory as HU controls and resolve the differences at functional level. How the continuous conditioning of the infant gut by the microbiota from the breast milk affects the infant microbiome and subsequent
October 7, 2020

Intergenerational Epigenomics of Trauma and PTSD in Rwanda

The goal of the proposed work is to characterize the transgenerational genomic impact of genocide exposure and post-traumatic stress disorder (PTSD) in women survivors of the Rwandan genocide and their offspring. PTSD is a common and debilitating mental disorder that has a profound public health impact. Between April and June 1994, almost one million people died in the Rwandan genocide against ethnic Tutsi.
October 6, 2020

Transgenerational Effects of Maternal Stressors: Investigating the Role of Infant Gene Expression

This collaborative project, between Emory University in the USA and the University of Cape Town (UCT) in South Africa, proposes to investigate biological mechanisms underlying the transgenerational effects of exposure to prenatal maternal psychological stress, anxiety, or depression. We propose to examine
October 1, 2020

Immunoglobulin Gene Diversity in an African Population and Impact Antibody Function in HIV Infection

Antibodies are critical components of immune defense and are mediators of vaccine-elicited protection as well as autoimmunity. The heavy and light chains that comprise an antibody molecule are encoded by germline immunoglobulin (Ig) gene fragments that recombine and undergo somatic mutation thereby generating billions of specificities able to contend with a multitude of foreign antigens.
October 1, 2020

Nurturing Genomics and Bioinformatics Research Capacity in Africa (BRECA)

Bioinformatics is now integral to clinical and biomedical research. Without bioinformatics expertise, health research in Africa will remain suboptimal. In fact, researchers on the continent are stuck with Next Generation Sequencing data that they can barely analyze.
September 29, 2020

African Neurobiobank for Precision Stroke Medicine: ELSI Project

African Neurobiobank for Precision Stroke Medicine: ELSI Project: Project Summary Africa had, hitherto, been under-represented in the biobanking revolution. However, with the Human, Heredity and Health in Africa (H3Africa) initiative, biorepository science has been bolstered and biobanking related activities are growing on the continent